Literature DB >> 25748122

New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.

Afaf R Genady1, Joseph A Ioppolo2, Mohamed M Azaam3, Mohamed E El-Zaria3.   

Abstract

A series of mercaptoundecahydrododecaborate (B12H11SH(2-), BSH) bearing mono- and dicarboxyalkyl derivatives was prepared, characterized, and their reactivity towards amidation and esterification in DMF was evaluated. Symmetrical alkylation of BSH was achieved by treatment with primary haloalkyl carboxylic acids in aqueous acetonitrile to produce S,S-bis(carboxyalkyl)sulfonium-undecahydro-closo-dodecaborate tetramethylammonium salts. Unsymmetrically substituted sulfonium salts were obtained through a similar treatment of cyanoethylthioether-undecahydro-closo-dodecaborate tetramethylammonium salt with haloalkyl carboxylic acid. Selective removal of the remaining cyanoethyl group upon treatment with tetramethylammonium hydroxide yielded S-carboxyalkyl-thioether-undecahydro-closo-dodecaborate ditetramethylammonium salts. N,N'-dicyclohexylcarbodiimide (DCC) activated amidation of S,S-bis(carboxyalkyl)sulfonium-undecahydro-closo-dodecaborate or S-carboxyalkyl-thioether-undecahydro-closo-dodecaborate tetramethylammonium salts with propargylamine provided the opportunity to install terminal acetylene groups for further conjugation. These compounds acted as powerful building blocks for the synthesis of a broad range of 1,4-disubstituted 1,2,3-triazole products in high yields, utilizing the Cu(I)-mediated click cycloaddition reaction. The synthesis of BSH-lipid with a two-tailed moiety was also achieved, by esterification of S,S-bis(carboxyethyl)sulfoniumundecahydro-closo-dodecaborate(1-) tetramethylammonium salt with 1,2-O-distearoyl-sn-3-glycerol, which may prove useful in the liposomal boron delivery system. The bio-compatibility of the azide-alkyne click reaction was then utilized by performing this reaction in cell culture. The distribution of BSH in HeLa cells could be visualized by treating the cells first with a BSH-alkyne compound and then with Alexa Fluor 488(®) azide dye. The BSH-dye conjugate, which did not wash out, revealed the distribution of boron in the HeLa cells. Cytotoxicity assays of these BSH derivatives revealed that the synthesized BSH-conjugated triazoles possessed low cytotoxicity in HeLa cancer cells. Of these compounds, BSH conjugated triazole 15 induced a significant increase in the level of boron accumulation in HeLa cells.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Amidation; BNCT; Click chemistry; Esterification; Imaging; NMR spectroscopy

Mesh:

Substances:

Year:  2015        PMID: 25748122     DOI: 10.1016/j.ejmech.2015.02.033

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma.

Authors:  Micah John Luderer; Barbara Muz; Pilar de la Puente; Sanmathi Chavalmane; Vaishali Kapoor; Raymundo Marcelo; Pratim Biswas; Dinesh Thotala; Buck Rogers; Abdel Kareem Azab
Journal:  Pharm Res       Date:  2016-07-11       Impact factor: 4.200

2.  MiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R.

Authors:  Hong-An Yang; Xiang Wang; Feng Ding; Qi Pang
Journal:  Med Sci Monit       Date:  2015-12-13

3.  Quantitative analysis of prompt gamma ray imaging during proton boron fusion therapy according to boron concentration.

Authors:  Han-Back Shin; Moo-Sub Kim; Sunmi Kim; Kyu Bom Kim; Joo-Young Jung; Do-Kun Yoon; Tae Suk Suh
Journal:  Oncotarget       Date:  2017-12-14

4.  Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.

Authors:  Ting Sun; Yanyan Li; Yulun Huang; Zizhu Zhang; Weilian Yang; Ziwei Du; Youxin Zhou
Journal:  Oncotarget       Date:  2016-07-12

5.  Primary Amine Nucleophilic Addition to Nitrilium Closo-Dodecaborate [B12H11NCCH3]-: A Simple and Effective Route to the New BNCT Drug Design.

Authors:  Alexey V Nelyubin; Nikita A Selivanov; Alexander Yu Bykov; Ilya N Klyukin; Alexander S Novikov; Andrey P Zhdanov; Natalia Yu Karpechenko; Mikhail S Grigoriev; Konstantin Yu Zhizhin; Nikolay T Kuznetsov
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.